Integrating asthma hazard characterization methods for consumer products

Regulatory Toxicology and Pharmacology

Volumn 70, Issue 1, 2014, Pages 37-45

  Maier, A ^a   Vincent, M J ^b   Gadagbui, B ^b   Patterson, J ^b   Beckett, W ^c   Dalton, P ^d   Kimber, I ^e   Selgrade, M J K ^f  

^a UNIVERSITY OF CINCINNATI   (United States)

^b Toxicology Excellence for Risk Assessment   (United States)

^c MOUNT AUBURN HOSPITAL   (United States)

^d MONELL CHEMICAL SENSES CENTER   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f ICF INTERNATIONAL   (United States)

Author keywords

Asthma; Consumer products; Hazard characterization

Indexed keywords

DOMESTIC CHEMICAL; TOXIC SUBSTANCE;

ACUTE TOXICITY; ALLERGIC ASTHMA; ARTICLE; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DECISION TREE; DISEASE EXACERBATION; ENVIRONMENTAL EXPOSURE; HAZARD ASSESSMENT; HEALTH HAZARD; HUMAN; OCCUPATIONAL ASTHMA; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PRODUCT SAFETY; RISK ASSESSMENT; SKIN SENSITIZATION; VALIDATION PROCESS; ADVERSE EFFECTS; ANIMAL; ASTHMA; IMMUNOLOGY; OCCUPATIONAL EXPOSURE; PROCEDURES; THEORETICAL MODEL;

ANIMALS; ASTHMA; CONSUMER PRODUCT SAFETY; DECISION TREES; HUMANS; MODELS, THEORETICAL; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT;

EID: 84903893502     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2014.06.009     Document Type: Article

References (46)

1. ACI (American Cleaning Institute), 2012. Industry Sponsored Asthma Science Forum: Report of Workshop held May 10, 2011. < http://www.cleaninginstitute.org/assests/1/Page/AsthmaScienceForumReport.pdf.
2. Andersson S.E., et al. The LLNA: A brief review of recent advances and limitations. J. Allergy. 2011, 2011:10. (Article ID 424203). 10.1155/2011/424203.
3. AOEC, 2008. Revised Protocol: Criteria for Designating Substances as Occupational Asthmagens on the AOEC List of Exposure Codes.
4. Arts J.H.E., Kuper C.F. Animal models to test respiratory allergy of low molecular weight chemicals: a guidance. Methods 2007, 41:61-71.
5. Arts J.H.E., de Jong W.H., van Triel J.J., Schijf M.A., de Klerk A., van Loveren H., Kuper C.F. The respiratory local lymph node assay as a tool to study respiratory sensitizers. Toxicol. Sci. 2008, 106(2):423-434.
6. ATS (American Thoracic Society), 2010. Asthma, In: Schraufnagel, D.E., (Ed.), Breathing in America: Diseases, Progress, and Hope. < http://www.thoracic.org/education/breathing-in-america/resources/chapter-3-asthma.pdf.
7. Barath S., Mills N.L., Adelroth E., Olin A.-C., Blomber A. Diesel exhaust but not ozone increases fraction of exhaled nitric oxide in a randomized controlled experimental exposure study of healthy human subjects. Environ. Health 2013, 12:36.
8. Baur X., Bakehe P., Vellguth H. Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach. J. Occup. Med. Toxicol. 2012, 7:19.
9. Bergeron C., Hamid Q. Relationship between asthma and rhinitis: epidemiologic, pathophysiologic, and therapeutic aspects. Allergy Asthma Clin. Immunol. 2005, 1(2):81-87.
10. Bernstein J.A. Reactive Airways Dysfunction Syndrome (RADS) 1993, DPICtions, (12, pp. 1-3).
11. Bernstein I.L., Chan-Yeung M., Malo J.-C., Bernstein D.I. Asthma in the Workplace 2006, Taylor & Francis Group, LLC, New York, NY. 3rd ed.
12. BTS (British Thoracic Society), 2009. British Guideline on the Management of Asthma: A National Clinical Guideline. < http://www.brit-thoracic.org.uk/Portals/0/Guidelines/AsthmaGuidelines/sign101%20revised%20June%2009.pdf.
13. Caceres A.I., Brackmann M., Elia M.D., et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. PNAS 2009, 106(22):9099-9104.
14. Centers for Disease Control and Prevention. Work Related Asthma 38 States and District of Columbia, 2006-2009. MMWR/May 25, 2012/Vol. 61/No. 20.
15. Dalton P. Evaluating the human response to sensory irritation: implications for setting occupational exposure limits. AIHAJ 2001, 62(6):723-729.
16. Donohue J.F., Jain N. Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates. Resp Med. 2013, 107(7):943-952.
17. Doty R.L., Cometto-Muniz J.E., Jalowayski A.A., Dalton P., Kendal-Reed M., Hodgson M. Assessment of upper respiratory tract and ocular irritative effects of volatile chemicals in humans. Crit. Rev. Toxicol. 2004, 34(2):85-142.
18. NO) for clinical applications. Am. J. Respir. Crit. Care Med. 2011, 184:602-615.
19. EU (European Union), 2013. Major and Chronic Diseases: Asthma. Available from: <. http://ec.europa.eu/health/major_chronic_diseases/diseases/asthma/index_en.htm.
20. Hunting, McDonald Development of a hierarchical exposure coding system for clinic-based surveillance of occupational disease and injury. Appl. Occup. Environ. Hyg. 1995, 10.
21. IPCS, 2012. Guidance for immunotoxicity risk assessment for chemicals. Harmonization Project Document No. 10. World Health Organization.
22. Jaakkola J.J.K., Jaakkola M.S. Professional cleaning and asthma. Curr. Opin. Allergy Clin. Immunol. 2006, 6:85-90.
23. Kimber I., Dearman R.J. Chemical respiratory allergy: role of IgE antibody and relevance of route of exposure. Toxicology 2002, 27(181-182):311-315.
24. Lemanske R.F., Busse W.W. Asthma: clinical expression and molecular mechanisms. J. Allergy Clin. Immunol. 2010, 125(2 S2):S95-S102.
25. Linkov I., Loney D., Cormier S., Satterstrom F.K., Bridges T. Weight-of-evidence evaluation in environmental assessment: review of qualitative and quantitative approaches. Sci. Total Environ. 2009, 407(19):5199-5205.
26. Mapp C.E., et al. Mechanisms and pathology of occupational asthma. Eur. Respir. J. 1994, 7:544-554.
27. Mapp C.E., Boschetto P., Maestrelli P., Fabbri L.M. Occupational asthma. Am. J. Respir. Crit. Care Med. 2005, 172:280-305.
28. Mayo Clinic, 2012. Asthma. Available from: <. http://www.mayoclinic.com/health/asthma/DS00021.
29. NHLBI (National Heart, Lung, and Blood Institute), 2007. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Asthma Education and Prevention Program. U.S. Department of Health and Human Services. National Institutes of Health. <. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
30. Nielsen G.D., et al. Do indoor chemicals promote development of airway allergy?. Indoor Air 2007, 17:236-255.
31. NIH (National Institutes of Health), 2012. Healthy Environments: A compilation of substances linked to asthma. Prepared by Perkins+Will for the NIH Division of Environmental Protection.
32. NLM (National Library of Medicine), 2013. A.D.A.M. Medical Encyclopedia: Asthma. PubMed Health. Available from: <. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001196/.
33. Quirce S., Barranco P. Cleaning agents and asthma. J. Investig. Allergol. Clin. Immunol. 2010, 20(7):542-550.
34. Rhomberg L.R., Goodman J.E., Bailey L.A., et al. A survey of frameworks for best practices in weight-of-evidence analyses. Crit. Rev. Toxicol. 2013, 43(9):753-784.
35. Rosenman K., et al. Cleaning products and work-related asthma. JOEM 2003, 2003(45):556-563.
36. Sanderson M.J. Exploring lung physiology in health and disease with lung slices. Pulm. Pharm. Ther. 2011, 24:452-465.
37. Selgrade, et al. Inconsistencies between cytokine profiles, antibody responses, and respiratory hyperresponsiveness following dermal exposure to isocyanates. Toxicol. Sci. 2006, 94(1):1080117.
38. Selgrade M.K., et al. Decision trees for evaluating skin and respiratory sensitizing potential of chemicals in accordance with European regulations. Regul. Toxicol. Pharm. 2012, 63:371-380.
39. Switalla S., Knebel J., Ritter D., Krug N., Braun A., Sewald K. Effects of acute in vitro exposure of murine precision-cut lung slices to gaseous nitrogen dioxide and ozone in an air-liquid interface (ALI) culture. Toxicol. Lett. 2010, 196:117-124.
40. TERA (Toxicology Excellence for Risk Assessment), 2014. Characterizing Potential Chemical Asthma Hazards: A Weight of Evidence Method and Case Study for Acetic Acid. Available from: <. http://www.tera.org/ART/ACI%20WoE%20White%20Paper%206-2-14.pdf.
41. US EPA (United States Environmental Protection Agency), 2010. The Cost of Illness Handbook. Chapter IV.2: Cost of Asthma. Available from: <. http://www.epa.gov/opptintr/coi/pubs/iv_2.pdf.
42. Vandebriel R.J., van Loveren H. Non-animal sensitization testing: state-of-the-art. Crit. Rev. Toxicol. 2010, 40:389-404.
43. Walker C., et al. Allergic and non-allergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 1992, 146:109-115.
44. WHO (World Health Organization), 2013. Asthma: Definition. Available from: <. http://www.who.int/respiratory/asthma/definition/en/.
45. Zock J.P. World at work: cleaners. Occup. Environ. Med. 2005, 62:581-584.
46. Zock J.P., Vizcaya D., Le Moual N. Update on asthma and cleaners. Curr. Opin. Allergy Clin. Immunol. 2010, 10(2):114-120.